US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Korro Bio, Inc.

12.71

-0.8800-6.48%

Post-market: 13.340.6300+4.96%17:20 EDT

Volume:75.87K

Turnover:975.62K

Market Cap:119.35M

PE:-1.35

High:13.63

Open:13.34

Low:12.60

Close:13.59

Loading ...

Overview Company News Filings

RBC Capital Reaffirms Their Buy Rating on Korro Bio (KRRO)

RBC Cuts Price Target on Korro Bio to $85 From $95, Keeps Outperform, Speculative Risk

MT Newswires Live

Analysts Conflicted on These Healthcare Names: OS Therapies Incorporated (OSTX), Korro Bio (KRRO) and Veeva Systems (VEEV)

Korro Bio Inc. Conducted Annual Stockholders Meeting

Korro Bio Is Maintained at Buy by Chardan Capital

Oppenheimer Adjusts Korro Bio Price Target to $90 From $155, Maintains Outperform Rating

MT Newswires Live

Korro Bio Inc expected to post a loss of $2.58 a share - Earnings Preview

Korro Bio price target lowered to $53 from $130 at H.C. Wainwright

Korro Bio Inc : Jonestrading Cuts Target Price to $53 From $130

THOMSON REUTERS

Korro Bio Is Maintained at Buy by HC Wainwright & Co.

Korro Bio to Cut 20% of Workforce

BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing

Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing

THOMSON REUTERS

Korro Bio Q1 EPS $(2.49) Beats $(2.61) Estimate, Sales $2.55M Beat $180.00K Estimate

Press Release: Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Cantor Fitzgerald Initiates Korro Bio at Overweight $74 Price Target

MT Newswires Live

Korro Bio Initiated at Buy by Chardan Capital

U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia

Korro Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Price Target $25

THOMSON REUTERS

Press Release: Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KRRO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":12.71,"timestamp":1752264000000,"preClose":13.59,"halted":0,"volume":75868,"hourTrading":{"tag":"盘后","latestPrice":13.34,"preClose":12.71,"latestTime":"17:20 EDT","volume":268,"amount":3529.18,"timestamp":1752268821684},"delay":0,"floatShares":4888172,"shares":9390492,"eps":-9.437878,"marketStatus":"Market Closed","change":-0.88,"latestTime":"07-11 16:00:00 EDT","open":13.34,"high":13.625,"low":12.6,"amount":975623.2618,"amplitude":0.075423,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.437878,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":13.59,"postHourTrading":{"tag":"盘后","latestPrice":13.34,"preClose":12.71,"latestTime":"17:20 EDT","volume":268,"amount":3529.18,"timestamp":1752268821684},"volumeRatio":0.754942438524136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":4888172,"roa":"-29.82%","roe":"-60.22%","lyrEps":-9.369477,"volumeRatio":0.754942438524136,"shares":9390492,"dividePrice":0,"high":13.625,"amplitude":0.075423,"preClose":13.59,"low":12.6,"week52Low":10.29,"pbRate":"0.86","psRate":"24.76","week52High":98,"institutionHeld":0,"latestPrice":12.71,"eps":-9.437878,"divideRate":0,"volume":75868,"delay":0,"ttmEps":-9.437878,"open":13.34,"prevYearClose":38.07,"prevWeekClose":13.35,"prevMonthClose":12.49,"prevQuarterClose":12.49,"fiveDayClose":13.35,"twentyDayClose":14.87,"sixtyDayClose":12.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549554955","title":"RBC Capital Reaffirms Their Buy Rating on Korro Bio (KRRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549554955?lang=en_us&edition=fundamental","pubTime":"2025-07-08 01:45","pubTimestamp":1751910317,"startTime":"0","endTime":"0","summary":"In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Korro Bio, with a price target of $85.00. The company’s shares op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-korro-bio-krro-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-korro-bio-krro-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO"],"gpt_icon":0},{"id":"2549453121","title":"RBC Cuts Price Target on Korro Bio to $85 From $95, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2549453121","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549453121?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:48","pubTimestamp":1751888891,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of buy and mean price target of $94.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO"],"gpt_icon":0},{"id":"2547009034","title":"Analysts Conflicted on These Healthcare Names: OS Therapies Incorporated (OSTX), Korro Bio (KRRO) and Veeva Systems (VEEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2547009034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547009034?lang=en_us&edition=fundamental","pubTime":"2025-06-30 21:40","pubTimestamp":1751290811,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OS Therapies Incorporated (OSTX – Research Report)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-os-therapies-incorporated-ostx-korro-bio-krro-and-veeva-systems-veev-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-os-therapies-incorporated-ostx-korro-bio-krro-and-veeva-systems-veev-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","KRRO","BK4534","LU1989764748.USD","BK4167","LU0266013472.USD","LU0170899867.USD","BK4504","LU0058720904.USD","VEEV","BK4613","LU1989764664.SGD","LU0289739699.SGD","OSTX","BK4137","BK4585","HCSG","BK4139","BK4528"],"gpt_icon":0},{"id":"2542537610","title":"Korro Bio Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542537610","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542537610?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:23","pubTimestamp":1749673426,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. held its annual meeting of stockholders on June 11, 2025. During the meeting, stockholders elected Ram Aiyar, Jean-Franois Formela, and Katharine Knobil as Class III directors. Additionally, stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. All proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDLbWzshj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2535357720","title":"Korro Bio Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2535357720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535357720?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:21","pubTimestamp":1747174860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2025 18:21 ET (22:21 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2535777989","title":"Oppenheimer Adjusts Korro Bio Price Target to $90 From $155, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535777989","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535777989?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:21","pubTimestamp":1747142485,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of Buy and mean price target of $95.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO","OPY"],"gpt_icon":0},{"id":"2534979102","title":"Korro Bio Inc  expected to post a loss of $2.58 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534979102","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534979102?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:01","pubTimestamp":1746788493,"startTime":"0","endTime":"0","summary":"Korro Bio Inc  expected to post a loss of $2.58 a share - Earnings Preview Korro Bio Inc KRRO.OQ KRRO.O is expected to show a rise in quarterly revenue when it reports  results  for the period ending ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH18R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2533132614","title":"Korro Bio price target lowered to $53 from $130 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2533132614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533132614?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:31","pubTimestamp":1746714693,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Korro Bio (KRRO) to $53 from $130 and keeps a Buy rating on the shares. The company reported Q1 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-lowered-to-53-from-130-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-lowered-to-53-from-130-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2533852271","title":"Korro Bio Inc : Jonestrading Cuts Target Price to $53 From $130","url":"https://stock-news.laohu8.com/highlight/detail?id=2533852271","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533852271?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:26","pubTimestamp":1746703579,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG3KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2533207185","title":"Korro Bio Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2533207185","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533207185?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:20","pubTimestamp":1746703200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 07:20 ET (11:20 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2533958439","title":"Korro Bio to Cut 20% of Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2533958439","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533958439?lang=en_us&edition=fundamental","pubTime":"2025-05-08 06:29","pubTimestamp":1746656940,"startTime":"0","endTime":"0","summary":"Korro Bio plans to cut about 20% of its workforce in an attempt to streamline operations and reach key program milestones.The clinical-stage biopharmaceutical company said Wednesday the restructuring will incur one-time charges of around $1.2 million, including employee severance, benefits and other termination costs. It expects to recognize the majority of those charges in the second quarter.Korro had 104 full-time employees as of Dec. 31, according to the company's most recent 10K filing.The actions will help the company complete its Phase 1/2a Rewrite clinical trial in 2026, nominate a second development candidate and advance up to two programs under a collaboration with Novo Nordisk, Korro said.The company will also continue to prioritize the development of KRRO-110 alongside investments in its Oligonucleotide Promoted Editing of RNA platform.Based in Cambridge, Mass., Korro is focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prev","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2533938459","title":"BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533938459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533938459?lang=en_us&edition=fundamental","pubTime":"2025-05-08 06:04","pubTimestamp":1746655482,"startTime":"0","endTime":"0","summary":"BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC FilingKorro Bio Inc KRRO.O:KORRO BIO INC - ANNOUNCES 20% WORKFORCE REDUCTION - SEC FILINGSource text: [ID:n0000950170-25-065786]Further company coverage: KRRO.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF1WY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2533625179","title":"Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533625179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533625179?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:59","pubTimestamp":1746651553,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF1WY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2533649979","title":"Korro Bio Q1 EPS $(2.49) Beats $(2.61) Estimate, Sales $2.55M Beat $180.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533649979","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533649979?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:40","pubTimestamp":1746650451,"startTime":"0","endTime":"0","summary":"Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.49) per share which beat the analyst consensus estimate of $(2.61) by 4.6 percent. This is a 2.05 percent decrease over losses of $(2.44) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268204/korro-bio-q1-eps-2-49-beats-2-61-estimate-sales-2-55m-beat-180-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2533297961","title":"Press Release: Korro Reports First Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533297961","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533297961?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:30","pubTimestamp":1746649800,"startTime":"0","endTime":"0","summary":"--  Interim readout from Phase 1/2a REWRITE clinical trial. reductions expected to extend cash runway into 2027. --  Second development candidate expected to be announced. --  Ended first quarter 2025 with $139.0 million in cash,Ram Aiyar, Ph.D., CEO and President of Korro, said, \"We remain on track to achieve our clinical and pipeline milestones, most notably reporting interim data from our Phase 1/2a REWRITE clinical trial of KRRO-110 in the second half of 2025. We believe that KRRO-110 represents a groundbreaking therapy with best-in-class potential for patients with AATD. At the same time, we remain focused on executing our 3-2-1 strategy through 2027 with the goal of developing novel genetic medicines to improve lives of patients with rare and highly prevalent diseases.\". generating program milestones. Korro is streamlining its operations. across the organization and reducing its workforce by approximately 20%. to advance its programs to key value inflection points, including. sec","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","RNA","TM","BK4139","BK4555","BK4099","BK4588","03160","BK4505","BK4585","KRRO"],"gpt_icon":0},{"id":"2531878910","title":"Cantor Fitzgerald Initiates Korro Bio at Overweight $74 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2531878910","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531878910?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:17","pubTimestamp":1745925479,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of buy and mean price target of $111.89, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO"],"gpt_icon":0},{"id":"2527297873","title":"Korro Bio Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2527297873","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527297873?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:20","pubTimestamp":1744802400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 16, 2025 07:20 ET (11:20 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2527525939","title":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2527525939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527525939?lang=en_us&edition=fundamental","pubTime":"2025-04-16 15:47","pubTimestamp":1744789663,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia April 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including 3M, Citigroup and N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU0JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","IEX","CARR","LU2468319806.SGD","ARI","EPAM","AOS","FTV","KREF","MCK","LU0640476718.USD","ATO","LU0256863902.USD","MMM","JBHT","IE00B42XCP33.USD","AGNC","LNN","AME","FBK","BMI","IE00BN0W2T93.GBP","GGG","LII","LU1721427968.SGD","FLNC","CPAY","LU1496350171.SGD","CCNE","ABR","BOW","AXTA","EMR","HON","IE00BQXX3F31.USD","KRRO","NLY","DOV","FLS","GTES","BE","HWC","CAH","IBKR","GO","LU1934455863.HKD","BK4533","BXMT","COR"],"gpt_icon":1},{"id":"2527728727","title":"Korro Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Price Target $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2527728727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527728727?lang=en_us&edition=fundamental","pubTime":"2025-04-16 12:07","pubTimestamp":1744776475,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2524978661","title":"Press Release: Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524978661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524978661?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:30","pubTimestamp":1743507000,"startTime":"0","endTime":"0","summary":"Strengthens leadership team with additional key appointment of GaoZhong Zhu, Ph.D. as Senior Vice President of Chemistry, Manufacturing and Controls  & Technical Operations and promotion of Oliver Dolan to Principal Accounting Officer. CAMBRIDGE, Mass., April 01, 2025  -- Korro Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today the appointment of Loc Vincent, Ph.D., as the Company's Chief Scientific Officer.\"We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific team and strategy,\" said Ram Aiyar, Ph.D., CEO and President of Korro. \"He joins us at an important time as we advance multiple candidates in our pipeline, including KRRO-110, which is currently being evaluated in the Phase 1/2a REWRITE clinical stu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0170899867.USD","IE00BZ1G4Q59.USD","LU0971096721.USD","LU0267386448.USD","LU0882574139.USD","CMC","BK4006","IE00BKVL7J92.USD","LU0149725797.USD","LU1363072403.SGD","IE00BHPRN162.USD","KRRO","IE00B1BXHZ80.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"KRRO","fiscalQuarterEnding":"2025/03","expectedEps":-2.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-2.49},{"market":"US","date":"2025-03-18","symbol":"KRRO","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-2.26},{"market":"US","date":"2024-11-12","symbol":"KRRO","fiscalQuarterEnding":"2024/09","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.26},{"market":"US","date":"2024-08-13","symbol":"KRRO","fiscalQuarterEnding":"2024/06","expectedEps":-2.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.43},{"market":"US","date":"2024-05-14","symbol":"KRRO","fiscalQuarterEnding":"2024/03","expectedEps":-2.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-2.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1745899200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2025-07-10","current":-1.581358,"percent":0.901266,"low":-8.894386,"twenty":-5.995177,"median":-4.640632,"eighty":-2.386662,"high":-1.160235,"avg":-4.502089,"sd":1.883587,"marketCap":138228042},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450},{"date":"2025-05-02","current":-2.066365,"twenty":-6.177673,"median":-4.874702,"eighty":-3.775951,"marketCap":172708852},{"date":"2025-05-09","current":-1.654409,"twenty":-6.170108,"median":-4.860984,"eighty":-3.687236,"marketCap":144613576},{"date":"2025-05-16","current":-1.555575,"twenty":-6.148652,"median":-4.836663,"eighty":-3.631696,"marketCap":135974324},{"date":"2025-05-23","current":-1.591026,"twenty":-6.130879,"median":-4.78968,"eighty":-3.512031,"marketCap":139073186},{"date":"2025-05-30","current":-1.260144,"twenty":-6.108373,"median":-4.78372,"eighty":-3.223328,"marketCap":110150471},{"date":"2025-06-06","current":-1.32675,"twenty":-6.061356,"median":-4.749297,"eighty":-3.117918,"marketCap":115972576},{"date":"2025-06-13","current":-1.50186,"twenty":-6.034499,"median":-4.735087,"eighty":-2.776295,"marketCap":131279078},{"date":"2025-06-20","current":-1.338568,"twenty":-6.030043,"median":-4.699133,"eighty":-2.705652,"marketCap":117005530},{"date":"2025-06-27","current":-1.325676,"twenty":-6.018574,"median":-4.677957,"eighty":-2.666335,"marketCap":115878671},{"date":"2025-07-03","current":-1.43418,"twenty":-6.003199,"median":-4.660916,"eighty":-2.628422,"marketCap":125363068},{"date":"2025-07-10","current":-1.581358,"twenty":-5.995177,"median":-4.640632,"eighty":-2.386662,"marketCap":138228042}],"updateTime":1752307089157}}}